These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31768673)

  • 1. Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome.
    Nakayama S; Morita Y; Espinoza JL; Rai S; Taniguchi Y; Taniguchi T; Miyake Y; Tanaka H; Ashida T; Matsumura I
    Ann Hematol; 2020 Feb; 99(2):381-383. PubMed ID: 31768673
    [No Abstract]   [Full Text] [Related]  

  • 2. Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Lee E; Kim TM; Lim Y; Jeon YK; Go H; Kim CW; Heo DS
    J Clin Oncol; 2013 Jul; 31(19):e332-4. PubMed ID: 23715578
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly.
    Ikebe T; Sasaki H; Saburi Y; Ogata M
    Int J Hematol; 2015 Nov; 102(5):509-10. PubMed ID: 26440976
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach.
    Tapan U; Pestana JB; Lee JC; Lerner A
    Leuk Lymphoma; 2015 Feb; 56(2):505-7. PubMed ID: 24794809
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
    Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
    Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
    Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
    Yamaguchi K; Kubota Y; Kishimori C; Ohno H; Kidoguchi K; Kizuka-Sano H; Nishioka A; Katsuya H; Ando T; Kimura S
    Ann Hematol; 2020 Feb; 99(2):389-390. PubMed ID: 31848683
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
    Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
    Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
    [No Abstract]   [Full Text] [Related]  

  • 10. Epitrochlear lymphadenopathy.
    Pannu AK; Prakash G; Jandial A; Kopp CR; Kumari S
    Korean J Intern Med; 2019 Nov; 34(6):1396. PubMed ID: 30514055
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P
    J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
    Shah NN; Harrison N; Stonecypher M; Frank D; Amorosa V; Svoboda J
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e157-60. PubMed ID: 25027567
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR
    Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
    Yoon SE; Kim SJ; Yoon DH; Koh Y; Mun YC; Do YR; Choi YS; Yang DH; Kim MK; Lee GW; Suh C; Ko YH; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1283-1291. PubMed ID: 32333154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
    Johnston A; Salles G; Espinouse D; Felman P; André P; Berger F; Coiffier B
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):356-8. PubMed ID: 19064401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS; Xie JL; Zhang M; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
    Yu M; Zhang Q; Xu S; Yin T; Li F
    Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis.
    Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME
    J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.